Molecular pharmacology

Keyphrases

Publications

volume 106, number 1, 2024

Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Tatjana Abaffy, Olivia Fu, Maira Harume-Nagai, Josh M Goldenberg, Victor Kenyon, Terry Kenakin
Intracellular Allosteric Antagonist of the Olfactory Receptor OR51E2. Molecular pharmacology 106 (1) (2024)
Gissell A Sanchez, Alan V Smrcka, Emily M Jutkiewicz
Biasing G βγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. Molecular pharmacology 106 (1) (2024)
Gloria Benítez-King, Jesús Argueta, Armida Miranda-Riestra, Jairo Muñoz-Delgado, Rosa Estrada-Reyes
Interaction of the Melatonin/Ca 2+ -CaM Complex with Calmodulin Kinase II: Physiological Importance. Molecular pharmacology 106 (1) (2024)
Lori L Isom
Memorial Tribute to William Albert Catterall (1946-2024). Molecular pharmacology 106 (1) (2024)
Ali El-Kasaby, Danila Boytsov, Ameya Kasture, Günther Krumpl, Thomas Hummel, Michael Freissmuth, Walter Sandtner
Allosteric Inhibition and Pharmacochaperoning of the Serotonin Transporter by the Antidepressant Drugs Trazodone and Nefazodone. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Kaiyan Liu, Zhihui Li, Linhao Li, Scott Heyward, Shelley R Wang, Ling He, Hongbing Wang
Mechanistic Understanding of Dexamethasone-Mediated Protection against Remdesivir-Induced Hepatotoxicity. Molecular pharmacology 106 (1) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Gissell A Sanchez, Alan V Smrcka, Emily M Jutkiewicz
Biasing G βγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. Molecular pharmacology 106 (1) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Tatjana Abaffy, Olivia Fu, Maira Harume-Nagai, Josh M Goldenberg, Victor Kenyon, Terry Kenakin
Intracellular Allosteric Antagonist of the Olfactory Receptor OR51E2. Molecular pharmacology 106 (1) (2024)
Gloria Benítez-King, Jesús Argueta, Armida Miranda-Riestra, Jairo Muñoz-Delgado, Rosa Estrada-Reyes
Interaction of the Melatonin/Ca 2+ -CaM Complex with Calmodulin Kinase II: Physiological Importance. Molecular pharmacology 106 (1) (2024)
Gissell A Sanchez, Alan V Smrcka, Emily M Jutkiewicz
Biasing G βγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. Molecular pharmacology 106 (1) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Gavin M Traber, Ai-Ming Yu
The Growing Class of Novel RNAi Therapeutics. Molecular pharmacology 106 (1) (2024)
Gissell A Sanchez, Alan V Smrcka, Emily M Jutkiewicz
Biasing G βγ Downstream Signaling with Gallein Inhibits Development of Morphine Tolerance and Potentiates Morphine-Induced Nociception in a Tolerant State. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Xinyi Wang, Jessika Carvajal-Moreno, Xinyu Zhao, Junan Li, Victor A Hernandez, Jack C Yalowich, Terry S Elton
Circumvention of Topoisomerase II α Intron 19 Intronic Polyadenylation in Acquired Etoposide-Resistant Human Leukemia K562 Cells. Molecular pharmacology 106 (1) (2024)
Tatjana Abaffy, Olivia Fu, Maira Harume-Nagai, Josh M Goldenberg, Victor Kenyon, Terry Kenakin
Intracellular Allosteric Antagonist of the Olfactory Receptor OR51E2. Molecular pharmacology 106 (1) (2024)
Tatjana Abaffy, Olivia Fu, Maira Harume-Nagai, Josh M Goldenberg, Victor Kenyon, Terry Kenakin
Intracellular Allosteric Antagonist of the Olfactory Receptor OR51E2. Molecular pharmacology 106 (1) (2024)

volume 106, number 2, 2024

Nicholas Denomme, Ciria C Hernandez, Hailey A Bock, Rachel F Ohana, Shreeya Bakshi, Alexander M Sherwood, John D McCorvy, Paul F Daley, Wyeth B Callaway, Jacob M Hull, Andrew Alt, Lori L Isom, Nicholas V Cozzi
N -(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels. Molecular pharmacology 106 (2) (2024)
Nicholas Denomme, Ciria C Hernandez, Hailey A Bock, Rachel F Ohana, Shreeya Bakshi, Alexander M Sherwood, John D McCorvy, Paul F Daley, Wyeth B Callaway, Jacob M Hull, Andrew Alt, Lori L Isom, Nicholas V Cozzi
N -(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels. Molecular pharmacology 106 (2) (2024)
Nicholas Denomme, Ciria C Hernandez, Hailey A Bock, Rachel F Ohana, Shreeya Bakshi, Alexander M Sherwood, John D McCorvy, Paul F Daley, Wyeth B Callaway, Jacob M Hull, Andrew Alt, Lori L Isom, Nicholas V Cozzi
N -(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels. Molecular pharmacology 106 (2) (2024)
Nicholas Denomme, Ciria C Hernandez, Hailey A Bock, Rachel F Ohana, Shreeya Bakshi, Alexander M Sherwood, John D McCorvy, Paul F Daley, Wyeth B Callaway, Jacob M Hull, Andrew Alt, Lori L Isom, Nicholas V Cozzi
N -(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels. Molecular pharmacology 106 (2) (2024)
Nicholas Denomme, Ciria C Hernandez, Hailey A Bock, Rachel F Ohana, Shreeya Bakshi, Alexander M Sherwood, John D McCorvy, Paul F Daley, Wyeth B Callaway, Jacob M Hull, Andrew Alt, Lori L Isom, Nicholas V Cozzi
N -(4-Bromo-2,5-Dimethoxyphenethyl)-6-(4-Phenylbutoxy)Hexan-1-Amine (XOB): A Novel Phenylalkylamine Antagonist of Serotonin 2A Receptors and Voltage-Gated Sodium Channels. Molecular pharmacology 106 (2) (2024)
Yushun Wang, Xueping Wu
New Perspectives and Prospects of microRNA Delivery in Diabetic Wound Healing. Molecular pharmacology 106 (2) (2024)

volume 106, number 3, 2024

Sandeep K Ravala, John Joseph Grubb Tesmer
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors. Molecular pharmacology 106 (3) (2024)
Manead Khin, Lydia J Davis, Daniel D Lantvit, Jimmy Orjala, Joanna E Burdette
Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells. Molecular pharmacology 106 (3) (2024)
Manead Khin, Lydia J Davis, Daniel D Lantvit, Jimmy Orjala, Joanna E Burdette
Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells. Molecular pharmacology 106 (3) (2024)
Remi Janicot, Mikel Garcia-Marcos
Get Ready to Sharpen Your Tools: A Short Guide to Heterotrimeric G Protein Activity Biosensors. Molecular pharmacology 106 (3) (2024)
Sandeep K Ravala, John Joseph Grubb Tesmer
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors. Molecular pharmacology 106 (3) (2024)
Manead Khin, Lydia J Davis, Daniel D Lantvit, Jimmy Orjala, Joanna E Burdette
Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells. Molecular pharmacology 106 (3) (2024)
Sandeep K Ravala, John Joseph Grubb Tesmer
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors. Molecular pharmacology 106 (3) (2024)
Sandeep K Ravala, John Joseph Grubb Tesmer
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors. Molecular pharmacology 106 (3) (2024)
Remi Janicot, Mikel Garcia-Marcos
Get Ready to Sharpen Your Tools: A Short Guide to Heterotrimeric G Protein Activity Biosensors. Molecular pharmacology 106 (3) (2024)
Remi Janicot, Mikel Garcia-Marcos
Get Ready to Sharpen Your Tools: A Short Guide to Heterotrimeric G Protein Activity Biosensors. Molecular pharmacology 106 (3) (2024)
Manead Khin, Lydia J Davis, Daniel D Lantvit, Jimmy Orjala, Joanna E Burdette
Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells. Molecular pharmacology 106 (3) (2024)
Armida Miranda-Riestra, Montserrat G Cercós, Citlali Trueta, Julián Oikawa-Sala, Jesús Argueta, Luis A Constantino-Jonapa, Ricardo Cruz-Garduño, Gloria Benítez-King, Rosa Estrada-Reyes
Participation of Ca 2+ -Calmodulin-Dependent Protein Kinase II in the Antidepressant-Like Effects of Melatonin. Molecular pharmacology 106 (3) (2024)
Sandeep K Ravala, John Joseph Grubb Tesmer
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors. Molecular pharmacology 106 (3) (2024)
Remi Janicot, Mikel Garcia-Marcos
Get Ready to Sharpen Your Tools: A Short Guide to Heterotrimeric G Protein Activity Biosensors. Molecular pharmacology 106 (3) (2024)
Manead Khin, Lydia J Davis, Daniel D Lantvit, Jimmy Orjala, Joanna E Burdette
Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells. Molecular pharmacology 106 (3) (2024)
Remi Janicot, Mikel Garcia-Marcos
Get Ready to Sharpen Your Tools: A Short Guide to Heterotrimeric G Protein Activity Biosensors. Molecular pharmacology 106 (3) (2024)
Armida Miranda-Riestra, Montserrat G Cercós, Citlali Trueta, Julián Oikawa-Sala, Jesús Argueta, Luis A Constantino-Jonapa, Ricardo Cruz-Garduño, Gloria Benítez-King, Rosa Estrada-Reyes
Participation of Ca 2+ -Calmodulin-Dependent Protein Kinase II in the Antidepressant-Like Effects of Melatonin. Molecular pharmacology 106 (3) (2024)
Armida Miranda-Riestra, Montserrat G Cercós, Citlali Trueta, Julián Oikawa-Sala, Jesús Argueta, Luis A Constantino-Jonapa, Ricardo Cruz-Garduño, Gloria Benítez-King, Rosa Estrada-Reyes
Participation of Ca 2+ -Calmodulin-Dependent Protein Kinase II in the Antidepressant-Like Effects of Melatonin. Molecular pharmacology 106 (3) (2024)
Sandeep K Ravala, John Joseph Grubb Tesmer
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors. Molecular pharmacology 106 (3) (2024)

volume 105, number 6, 2024

King Clyde B Yabut, Alice Martynova, Abhinav Nath, Benjamin P Zercher, Matthew F Bush, Nina Isoherranen
Drugs Form Ternary Complexes with Human Liver Fatty Acid Binding Protein 1 (FABP1) and FABP1 Binding Alters Drug Metabolism. Molecular pharmacology 105 (6) (2024)
Jeffrey S Smith, Ari S Hilibrand, Meredith A Skiba, Andrew N Dates, Victor G Calvillo-Miranda, Andrew C Kruse
The M3 Muscarinic Acetylcholine Receptor Can Signal through Multiple G Protein Families. Molecular pharmacology 105 (6) (2024)
Jeffrey S Smith, Ari S Hilibrand, Meredith A Skiba, Andrew N Dates, Victor G Calvillo-Miranda, Andrew C Kruse
The M3 Muscarinic Acetylcholine Receptor Can Signal through Multiple G Protein Families. Molecular pharmacology 105 (6) (2024)